Formycon AG (LTS:0W4N) Days Inventory : 4.63 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Formycon AG Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Formycon AG's Average Total Inventories for the six months ended in Dec. 2023 was €0.72 Mil. Formycon AG's Cost of Goods Sold for the six months ended in Dec. 2023 was €28.24 Mil. Hence, Formycon AG's Days Inventory for the six months ended in Dec. 2023 was 4.63.

The historical rank and industry rank for Formycon AG's Days Inventory or its related term are showing as below:

LTS:0W4N' s Days Inventory Range Over the Past 10 Years
Min: 3.48 Med: 10.54 Max: 19.12
Current: 4.48

During the past 13 years, Formycon AG's highest Days Inventory was 19.12. The lowest was 3.48. And the median was 10.54.

LTS:0W4N's Days Inventory is ranked better than
98.62% of 654 companies
in the Biotechnology industry
Industry Median: 193.29 vs LTS:0W4N: 4.48

Formycon AG's Days Inventory increased from Dec. 2022 (2.89) to Dec. 2023 (4.63). It might indicate that Formycon AG's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Formycon AG's Inventory Turnover for the six months ended in Dec. 2023 was 39.44.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Formycon AG's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.02.

Formycon AG Days Inventory Historical Data

The historical data trend for Formycon AG's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG Days Inventory Chart

Formycon AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

12.75

9.46

11.62

7.58

3.48

Formycon AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial															12.74	5.15	2.89	5.36	4.63

Competitive Comparison of Formycon AG's Days Inventory

For the Biotechnology subindustry, Formycon AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Formycon AG's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's Days Inventory distribution charts can be found below:

* The bar in red indicates where Formycon AG's Days Inventory falls into.

Formycon AG Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Formycon AG's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.571	+	0.467)	/	2 )	/	54.391	*	365
=	0.519					/	54.391	*	365
=	3.48

Formycon AG's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.965	+	0.467)	/	2 )	/	28.238	*	365 / 2
=	0.716					/	28.238	*	365 / 2
=	4.63

Formycon AG (LTS:0W4N) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Formycon AG's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	28.238	/	0.716
	=	39.44

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Formycon AG's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.716	/	33.907
	=	0.02

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Formycon AG Days Inventory Related Terms

Thank you for viewing the detailed overview of Formycon AG's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Formycon AG (LTS:0W4N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (LTS:0W4N) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

FYB:Germany

Address

Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.formycon.com

Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.

Formycon AG (LTS:0W4N) Headlines

No Headlines